Dr. Phillip Drum - Why Medical Marijuana should Stay Level 1 Controlled Substance

Dr. Phillip Drum returns to The Addiction Podcast: Point of No Return to argue forcefully that medical marijuana should remain a Schedule I controlled substance due to its lack of FDA approval, significant health risks, and the dangers of legalization. He details the growing crisis of cannabis-induced hyperemesis syndrome (CIHS), a severe condition causing life-threatening vomiting, dehydration, and cardiac issues, which requires IV treatment and only resolves with cessation of cannabis use. Dr. Drum dismantles the claim that marijuana has medical value, noting that FDA-approved dronabinol (a synthetic THC) already exists for chemotherapy-induced nausea and AIDS wasting—conditions that are now rare. He warns that reclassifying marijuana to Schedule III would enable banking access for the industry, potentially exposing it to international drug cartels, and would trigger mandatory prescription drug monitoring programs (PDMPs), requiring budtenders to access sensitive patient data. He also highlights the failure of states to collect promised tax revenues, with Los Angeles losing $300 million in uncollected taxes. The episode further explores a controversial link between cannabis use and mass shooters, citing multiple high-profile cases where perpetrators were known or suspected cannabis users, and calls for mandatory THC testing in law enforcement, including hair and oral swab tests, to expose chronic use. Dr. Drum concludes by emphasizing that marijuana fails the five criteria of the 1938 Food, Drug, and Cosmetic Act to be considered a medicine.